Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) saw some unusual options trading activity on Tuesday. Stock investors bought 6,648 call options on the stock. This represents an increase of approximately 289% compared to the typical volume of 1,709 call options.
Semler Scientific Price Performance
Shares of Semler Scientific stock traded down $1.16 on Friday, hitting $29.58. 649,542 shares of the company's stock traded hands, compared to its average volume of 509,970. The firm's 50-day moving average price is $35.56 and its two-hundred day moving average price is $45.61. The stock has a market capitalization of $329.88 million, a PE ratio of 6.02 and a beta of 1.42. Semler Scientific has a one year low of $21.77 and a one year high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $8.84 million during the quarter.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
Read Our Latest Report on SMLR
Institutional Trading of Semler Scientific
A number of large investors have recently made changes to their positions in the company. Global Retirement Partners LLC increased its position in shares of Semler Scientific by 62.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock valued at $70,000 after buying an additional 500 shares in the last quarter. Kovitz Investment Group Partners LLC increased its position in shares of Semler Scientific by 2.2% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock valued at $1,236,000 after buying an additional 501 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Semler Scientific by 318.3% in the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after buying an additional 557 shares in the last quarter. BNP Paribas Financial Markets bought a new stake in shares of Semler Scientific in the 4th quarter valued at $30,000. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Semler Scientific by 10.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock valued at $225,000 after buying an additional 576 shares in the last quarter. Institutional investors own 49.37% of the company's stock.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
